Literature DB >> 15199734

[Pravastatin-associated polymyositis, a case report].

Akio Takagi1, Yasusi Shiio.   

Abstract

A 69 year old man complained of general myalgia, arthralgia and muscle weakness in two weeks after he started to take 10 mg per day pravastatin. Symptoms progressed at least for 3 months after withdrawal of the medication. The muscle weakness was more in distal upper extremities and the iliopsoas muscle. Serum CK was 943IU/L. The anti-nuclear and Jo-1 antibody were positive. EMG examinations disclosed fibrillation potentials at rest and myopathic discharges by a voluntary contractor. Symptoms as well as serum CK values improved promptly by treatment with prednisolone. From these clinical and laboratory results, it was speculated that this patient suffered from subacute polymyositis, although pathological studies were not performed. Because of continuing hypercholesterolemia, the patient was retreated with atorvastatin, presenting similar, but less serious symptoms. So far, three cases of statin-associated polymyositis or dermatomyositis were reported. Statins could influence the immune system, but it is still unsettled if statins cause autoimmune polymyositis. This problem warrants further study.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15199734

Source DB:  PubMed          Journal:  Rinsho Shinkeigaku        ISSN: 0009-918X


  5 in total

Review 1.  Update on toxic myopathies.

Authors:  F L Mastaglia; M Needham
Journal:  Curr Neurol Neurosci Rep       Date:  2012-02       Impact factor: 5.081

Review 2.  Statin adverse effects : a review of the literature and evidence for a mitochondrial mechanism.

Authors:  Beatrice A Golomb; Marcella A Evans
Journal:  Am J Cardiovasc Drugs       Date:  2008       Impact factor: 3.571

Review 3.  Lipid-lowering agent-triggered dermatomyositis and polymyositis: a case series and literature review.

Authors:  Isabela Bruna Pires Borges; Marilda Guimarães Silva; Rafael Giovane Misse; Samuel Katsuyuki Shinjo
Journal:  Rheumatol Int       Date:  2017-10-12       Impact factor: 2.631

4.  Statin use in patients with non-HMGCR idiopathic inflammatory myopathies: A retrospective study.

Authors:  Sangmee Sharon Bae; Buzand Oganesian; Ilana Golub; Christina Charles-Schoeman
Journal:  Clin Cardiol       Date:  2020-05-20       Impact factor: 2.882

Review 5.  Anti-HMGCR Myopathy.

Authors:  Payam Mohassel; Andrew L Mammen
Journal:  J Neuromuscul Dis       Date:  2018
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.